Halozyme Therapeutics, Inc. (HALO) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for HALO. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 650 institutions reported holding HALO, with 122.9 million shares worth $9.6 billion in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| BlackRock | 13,271,095 | $1.0B | INCREASED |
| Vanguard | 11,641,149 | $911M | INCREASED |
| State Street | 5,179,434 | $405M | INCREASED |
| Invesco Ltd | 3,177,997 | $249M | DECREASED |
| Morgan Stanley | 2,832,594 | $222M | INCREASED |
Recent Congressional Trades
| Member | Type | Amount | Date |
|---|---|---|---|
| Gilbert Cisneros (Democrat) | SALE | $1,001 - $15,000 | 2026-09-29 |
Full institutional holdings, insider history, and congressional trades for Halozyme Therapeutics, Inc. on SentiSense.